PPB - Services

Complaints, Feedback and Enquiry

Pharmacovigilance Summary Report: January-June 2021 (Q3 & 4)

  • Version
  • Download 528
  • File Size 526.47 KB
  • File Count 1
  • Create Date June 23, 2022
  • Last Updated June 23, 2022

Pharmacovigilance Summary Report: January-June 2021 (Q3 & 4)

The Pharmacy and Poisons Board is the Drug Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya. The Board regulates the Practice of Pharmacy and the manufacture and trade in drugs and poisons.

PPB has 4 directorates of which the Directorate of Medicines Information and Pharmacovigilance (MIPV) is responsible for Pharmacovigilance, Post-Market Surveillance, Clinical Trials & Medicines Information activities. MIPV shares quarterly pharmacovigilance reports with stakeholders to serve as a feedback mechanism and also encourage all stakeholders to report.

Since the introduction of PV in Kenya, a total of 14,589 individual case safety reports has been submitted to the global data reports 26,863,169 (0.05%).

Attached Files

PV Summary Reports_Q3&4_2020_2021.pdfDownload



Leave a comment

Your email address will not be published. Required fields are marked *